Agentic AI In Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2021-2031F

The Global Agentic AI in Healthcare Market is projected to expand significantly, growing from USD 189.23 Million in 2025 to USD 292.85 Million by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 7.55%. Agentic AI systems in healthcare are defined as autonomous technologies that can perceive clinical environments, interpret complex data, and execute specific tasks like patient triage or treatment planning with minimal human involvement. This market growth is primarily fueled by the urgent need to address healthcare workforce burnout and improve operational efficiency in overburdened health systems. The increasing demand for automated support is evidenced by high adoption rates; in 2024, the American Medical Association reported that 66% of physicians were already utilizing healthcare AI tools, demonstrating a solid foundation for these autonomous capabilities.

However, the market's expansion faces a substantial hurdle due to the intricate regulatory framework surrounding professional liability and accountability. The lack of clear legal guidelines on who is responsible for errors made by autonomous agents poses considerable risks for healthcare providers and technology developers. Without well-defined governance structures that differentiate between machine actions and human oversight, institutions may hesitate to widely integrate agentic systems into critical clinical workflows, driven by concerns about patient safety and potential litigation.

Market Driver

A primary catalyst for the widespread adoption of agentic AI systems is the pressing need to alleviate critical healthcare workforce shortages and combat clinician burnout. These autonomous agents are increasingly employed to reduce cognitive loads by independently managing electronic health records, streamlining patient triage, and executing administrative tasks, thereby lessening the operational pressures contributing to provider fatigue. The urgency of these applications is underscored by current staff inefficiencies; according to Philips' May 2025 'Future Health Index 2025' report, over 75% of healthcare professionals lose clinical time due to incomplete or inaccessible patient data, highlighting a vital demand for intelligent systems capable of processing information without constant human intervention.

Simultaneously, the acceleration of pharmaceutical drug discovery and the optimization of clinical trials are significant drivers of market expansion. Agentic AI transcends traditional static analysis by actively formulating hypotheses for molecular structures and simulating trial outcomes, drastically shortening the development timeline from initial concept to market launch. This pivot towards autonomous research and development is demonstrated by rapid industry integration; NVIDIA's August 2025 'State of AI in Healthcare and Life Sciences: 2025 Trends' report indicates that 69% of pharmaceutical and biotechnology firms are now actively leveraging generative AI technologies to spur innovation. This focused adoption reflects a broader organizational shift, as noted by SS&C Blue Prism's April 2025 'Global Enterprise AI Survey 2025', which found 94% of healthcare organizations now consider AI central to their operational strategies.

Market Challenge

The intricate regulatory environment concerning professional liability and accountability poses a significant impediment to the growth of the Global Agentic AI In Healthcare Market. As agentic systems autonomously analyze and interpret clinical data, they blur traditional boundaries of malpractice responsibility. In instances of error, the absence of distinct legal frameworks to differentiate between algorithmic faults and failures in human oversight creates an unacceptable risk profile for healthcare institutions. Consequently, providers are hesitant to deploy these technologies in sensitive clinical settings, fearing extensive litigation for decisions made by non-human agents under current ambiguous laws.

This institutional reluctance is supported by quantitative data on industry perceptions of governance. The American Medical Association reported in 2024 that 47% of physicians identified increased regulatory oversight as the top priority for building trust in AI-driven healthcare tools. This statistic underscores a disparity where technological advancements are outpacing the necessary governance structures. Without clear accountability standards to safeguard providers from undefined liability, the adoption of agentic AI is likely to remain confined to pilot programs rather than achieving widespread commercial integration.

Market Trends

A fundamental technological shift is underway, characterized by the Evolution from Generative Assistants to Autonomous Action Executors, where systems are moving beyond passive content creation to independently complete complex operational processes. Unlike earlier copilot models that necessitated continuous human input, these advanced agents now possess the capability to manage domain-specific workflows, such as executing inventory orders or conducting preliminary diagnostic screenings, with minimal oversight. This progression toward domain-centric autonomy is quickly gaining traction across the industry; an October 2025 Forbes article, 'AI Adoption In Healthcare Is Surging,' highlights that 22% of healthcare organizations have already implemented domain-specific AI tools, marking a seven-fold increase in adoption from the prior year.

Concurrently, the Emergence of Role-Specific Digital Workforce Platforms is redefining how health systems procure and deploy artificial intelligence. Rather than developing bespoke solutions, organizations are increasingly opting to subscribe to comprehensive libraries of pre-trained agents designed to function as specialized digital employees for tasks ranging from optimizing supply chains to reconciling finances. Leading technology vendors are actively capitalizing on this demand by transitioning from offering general-purpose toolkits to providing turnkey agent marketplaces; a CRN article from October 2025, 'Analysis: How Oracle Is Differentiating For The Agentic AI Era,' notes that Oracle now provides over 400 specialized AI agents within its Fusion application suite, enabling institutions to rapidly scale their autonomous capabilities.

Key Market Players

• nVIDIA Corporation
• Oracle Corporation
• Microsoft Corporation
• Thoughtful Automation Inc.
• Hippocratic AI Inc.
• Cognigy GmbH
• Amelia US LLC
• Beam AI Inc.
• Momentum AI (Momentum)
• Notable Health

Report Scope

In this report, the Global Agentic AI In Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Agentic AI In Healthcare Market, By Product

• Ready-to-Deploy Agents
• Multi Agent Systems

Agentic AI In Healthcare Market, By Application

• Medical Imaging
• Personalized Treatment & Drug Discovery
• Electronic Health Records (EHR)
• Remote Patient Care
• Genomic Data Analysis
• Chronic Disease Management
• Others

Agentic AI In Healthcare Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Agentic AI In Healthcare Market.

Available Customizations:

Global Agentic AI In Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).